Figure 3From: ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy Disease-free survival. Without adjuvant chemotherapy (a), with adjuvant chemotherapy (b) (interaction P = 0.20).Back to article page